|
|
||||||||
Radiology, Vol 200, 785-792, Copyright © 1996 by Radiological Society of North America
ARTICLES |
E Seneterre, P Taourel, Y Bouvier, J Pradel, B Van Beers, JP Daures, J Pringot, D Mathieu and JM Bruel
Department of Medical Imaging, Hopital St Eloi, Montpellier, France.
PURPOSE: To prospectively compare the diagnostic accuracy of computed tomography (CT) during arterial portography (CTAP) with that of unenhanced and ferumoxides-enhanced magnetic resonance (MR) imaging at 0.5 T in the detection of hepatic metastases. MATERIALS AND METHODS: Four pairs of radiologists independently assessed the metastatic involvement of 134 hepatic segments (31 with and 103 without metastasis) in 17 patients at unenhanced and ferumoxides-enhanced spin- echo and gradient-echo MR imaging (alone and in combination) and at CTAP. The diagnostic performance of the various imaging modalities was assessed by means of receiver operating characteristic analysis. RESULTS: The accuracy of CTAP, unenhanced MR imaging (combined unenhanced sequences), and ferumoxides-enhanced MR imaging (combined contrast material-enhanced sequences) was 0.925, 0.908, and 0.951, respectively. Ferumoxides-enhanced MR imaging was significantly more accurate (P < .05) than unenhanced MR imaging and CTAP. When 14 segments containing cysts were excluded, the difference between ferumoxides-enhanced MR imaging and CTAP was no longer statistically significant (P = .1). CONCLUSION: Ferumoxides-enhanced MR imaging is more accurate than unenhanced MR imaging and at least as accurate as CTAP for the detection of hepatic metastases.
This article has been cited by other articles:
![]() |
H. Furukawa, K. Uesaka, and N. Boku Treatment Decision Making in Pancreatic Adenocarcinoma: Multidisciplinary Team Discussion With Multidetector-Row Computed Tomography Arch Surg, March 1, 2008; 143(3): 275 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Hanna, N. Kased, S. W. Kwan, A. C. Gamst, A. C. Santosa, T. Hassanein, and C. B. Sirlin Double-Contrast MRI for Accurate Staging of Hepatocellular Carcinoma in Patients with Cirrhosis Am. J. Roentgenol., January 1, 2008; 190(1): 47 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. P. Hosch, S. M. Schmidt, S. Plaza, C. Dechow, J. Schmidt, S. Ley, G. W. Kauffmann, and J. Hansmann Comparison of CT during arterial portography and MR during arterial portography in the detection of liver metastases. Am. J. Roentgenol., June 1, 2006; 186(6): 1502 - 1511. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Kim, K. W. Kim, J. H. Byun, H. J. Won, Y. M. Shin, P. N. Kim, M.-S. Lee, and M.-G. Lee Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients. Am. J. Roentgenol., April 1, 2006; 186(4): 1059 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Onishi, T. Murakami, T. Kim, M. Hori, R. Iannaccone, M. Kuwabara, H. Abe, S. Nakata, K. Osuga, K. Tomoda, et al. Hepatic Metastases: Detection with Multi-Detector Row CT, SPIO-enhanced MR Imaging, and Both Techniques Combined Radiology, April 1, 2006; 239(1): 131 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nasu, Y. Kuroki, S. Nawano, S. Kuroki, T. Tsukamoto, S. Yamamoto, K. Motoori, and T. Ueda Hepatic Metastases: Diffusion-weighted Sensitivity-encoding versus SPIO-enhanced MR Imaging Radiology, April 1, 2006; 239(1): 122 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ward, P. J. Robinson, J. A. Guthrie, S. Downing, D. Wilson, J. P. A. Lodge, K. R. Prasad, G. J. Toogood, and J. I. Wyatt Liver Metastases in Candidates for Hepatic Resection: Comparison of Helical CT and Gadolinium- and SPIO-enhanced MR Imaging Radiology, October 1, 2005; 237(1): 170 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Sahani, S. P. Kalva, A. J. Fischman, R. Kadavigere, M. Blake, P. F. Hahn, and S. Saini Detection of Liver Metastases from Adenocarcinoma of the Colon and Pancreas: Comparison of Mangafodipir Trisodium-Enhanced Liver MRI and Whole-Body FDG PET Am. J. Roentgenol., July 1, 2005; 185(1): 239 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. K. Kim, C. S. Kim, Y. H. Lee, H. S. Kwak, and J. M. Lee Comparison of Superparamagnetic Iron Oxide-Enhanced and Gadobenate Dimeglumine-Enhanced Dynamic MRI for Detection of Small Hepatocellular Carcinomas Am. J. Roentgenol., May 1, 2004; 182(5): 1217 - 1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Kim, A. Y. Kim, T. K. Kim, S. H. Park, H. J. Kim, Y. K. Lee, M.-S. Park, H. K. Ha, P. N. Kim, J. C. Kim, et al. Small (l.e. 2cm) Hepatic Lesions in Colorectal Cancer Patients: Detection and Characterization on Mangafodipir Trisodium-Enhanced MRI Am. J. Roentgenol., May 1, 2004; 182(5): 1233 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matsuo, M. Kanematsu, K. Itoh, T. Murakami, Y. Maetani, H. Kondo, S. Goshima, N. Kako, H. Hoshi, J. Konishi, et al. Detection of Malignant Hepatic Tumors with Ferumoxides-Enhanced MRI: Comparison of Five Gradient-Recalled Echo Sequences with Different TEs Am. J. Roentgenol., January 1, 2004; 182(1): 235 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumano, T. Murakami, T. Kim, M. Hori, A. Okada, T. Sugiura, Y. Noguchi, S. Kawata, K. Tomoda, and H. Nakamura Using Superparamagnetic Iron Oxide-Enhanced MRI to Differentiate Metastatic Hepatic Tumors and Nonsolid Benign Lesions Am. J. Roentgenol., November 1, 2003; 181(5): 1335 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Pastor, C. Planchamp, S. Pochon, V. Lorusso, X. Montet, J. Mayer, F. Terrier, and J.-P. Vallee Kinetics of Gadobenate Dimeglumine in Isolated Perfused Rat Liver: MR Imaging Evaluation Radiology, October 1, 2003; 229(1): 119 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Kim, J. H. Kim, J.-J. Chung, M. S. Park, J. S. Lim, and Y. T. Oh Focal Hepatic Lesions: Detection and Characterization with Combination Gadolinium- and Superparamagnetic Iron Oxide-enhanced MR Imaging Radiology, September 1, 2003; 228(3): 719 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ward, J. A. Guthrie, D. Wilson, P. Arnold, J. P. Lodge, G. J. Toogood, J. I. Wyatt, and P. J. Robinson Colorectal Hepatic Metastases: Detection with SPIO-enhanced Breath-hold MR Imaging—Comparison of Optimized Sequences Radiology, September 1, 2003; 228(3): 709 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Bluemke, T. M. Weber, D. Rubin, E. E. de Lange, R. Semelka, R. D. Redvanly, J. Chezmar, E. Outwater, R. Carlos, S. Saini, et al. Hepatic MR Imaging with Ferumoxides: Multicenter Study of Safety and Effectiveness of Direct Injection Protocol Radiology, August 1, 2003; 228(2): 457 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Kamel, M. A. Choti, K. M. Horton, H. J. V. Braga, B. A. Birnbaum, E. K. Fishman, R. E. Thompson, and D. A. Bluemke Surgically Staged Focal Liver Lesions: Accuracy and Reproducibility of Dual-Phase Helical CT for Detection and Characterization Radiology, June 1, 2003; 227(3): 752 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Frate, C. Zuiani, V. Londero, G. Como, M. Bazzocchi, K. Mortele, and P. R. Ros Comparing Levovist-Enhanced Pulse Inversion Harmonic Imaging and Ferumoxides-Enhanced MR Imaging of Hepatic Metastases Am. J. Roentgenol., May 1, 2003; 180(5): 1339 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Kang, J. H. Lim, S. H. Kim, D. Choi, H. K. Lim, W. J. Lee, and S. J. Lee Preoperative Depiction of Hepatocellular Carcinoma: Ferumoxides-enhanced MR Imaging versus Triple-Phase Helical CT Radiology, January 1, 2003; 226(1): 79 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
T H Saunders, H K Mendes Ribeiro, and F V Gleeson New techniques for imaging colorectal cancer: the use of MRI, PET and radioimmunoscintigraphy for primary staging and follow-up Br. Med. Bull., December 1, 2002; 64(1): 81 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Del Frate, M. Bazzocchi, K. J. Mortele, C. Zuiani, V. Londero, G. Como, R. Zanardi, and P. R. Ros Detection of Liver Metastases: Comparison of Gadobenate Dimeglumine-enhanced and Ferumoxides-enhanced MR Imaging Examinations Radiology, December 1, 2002; 225(3): 766 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Arbab, T. Ichikawa, H. Sou, T. Araki, H. Nakajima, K. Ishigame, T. Yoshikawa, and H. Kumagai Ferumoxides-enhanced Double-Echo T2-weighted MR Imaging in Differentiating Metastases from Nonsolid Benign Lesions of the Liver Radiology, October 1, 2002; 225(1): 151 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Kim, S. H. Kim, W. J. Lee, H. Kim, J. W. Seo, D. Choi, H. K. Lim, S. J. Lee, and J. H. Lim Preoperative Detection of Hepatocellular Carcinoma: Ferumoxides-Enhanced Versus Mangafodipir Trisodium--Enhanced MR Imaging Am. J. Roentgenol., September 1, 2002; 179(3): 741 - 750. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oudkerk, C. G. Torres, B. Song, M. Konig, J. Grimm, J. Fernandez-Cuadrado, B. Op de Beeck, M. Marquardt, P. van Dijk, and J. C. de Groot Characterization of Liver Lesions with Mangafodipir Trisodium-enhanced MR Imaging: Multicenter Study Comparing MR and Dual-Phase Spiral CT Radiology, May 1, 2002; 223(2): 517 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Raman, D. S. K. Lu, S. C. Chen, J. Sayre, F. Eilber, and J. Economou Hepatic MR Imaging Using Ferumoxides: Prospective Evaluation with Surgical and Intraoperative Sonographic Confirmation in 25 Cases Am. J. Roentgenol., October 1, 2001; 177(4): 807 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matsuo, M. Kanematsu, K. Itoh, K. Ito, Y. Maetani, H. Kondo, N. Kako, N. Matsunaga, H. Hoshi, and J. Shiraishi Detection of Malignant Hepatic Tumors: Comparison of Gadolinium-and Ferumoxide-Enhanced MR Imaging Am. J. Roentgenol., September 1, 2001; 177(3): 637 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lim, D. Choi, S. K. Cho, S. H. Kim, W. J. Lee, H. K. Lim, C. K. Park, S. W. Paik, and Y. I. Kim Conspicuity of Hepatocellular Nodular Lesions in Cirrhotic Livers at Ferumoxides-enhanced MR Imaging: Importance of Kupffer Cell Number Radiology, September 1, 2001; 220(3): 669 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Mann, H. F. Marx, L. L. Lai, and L. D. Wagman Clinical and Cost Effectiveness of a New Hepatocellular MRI Contrast Agent, Mangafodipir Trisodium, in the Preoperative Assessment of Liver Resectability Ann. Surg. Oncol., August 1, 2001; 8(7): 573 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Maetani, K. Itoh, C. Watanabe, T. Shibata, F. Ametani, H. Yamabe, and J. Konishi MR Imaging of Intrahepatic Cholangiocarcinoma with Pathologic Correlation Am. J. Roentgenol., June 1, 2001; 176(6): 1499 - 1507. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Choi, S. H. Kim, J. H. Lim, W. J. Lee, H.-J. Jang, S. J. Lee, and H. K. Lim Preoperative Detection of Hepatocellular Carcinoma: Ferumoxides-Enhanced MR Imaging Versus Combined Helical CT During Arterial Portography and CT Hepatic Arteriography Am. J. Roentgenol., February 1, 2001; 176(2): 475 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Semelka and T. K. G. Helmberger Contrast Agents for MR Imaging of the Liver Radiology, January 1, 2001; 218(1): 27 - 38. [Abstract] [Full Text] |
||||
![]() |
C. Valls, E. Andía, A. Sánchez, A. Gumà, J. Figueras, J. Torras, and T. Serrano Hepatic Metastases from Colorectal Cancer: Preoperative Detection and Assessment of Resectability with Helical CT Radiology, January 1, 2001; 218(1): 55 - 60. [Abstract] [Full Text] |
||||
![]() |
D. A. Bluemke, E. K. Paulson, M. A. Choti, S. DeSena, and P. A. Clavien Detection of Hepatic Lesions in Candidates for Surgery: Comparison of Ferumoxides-Enhanced MR Imaging and Dual-Phase Helical CT Am. J. Roentgenol., December 1, 2000; 175(6): 1653 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hirohashi, K. Ueda, H. Uchida, W. Ono, J. Takahama, M. Takewa, S. Kitano, and H. Ohishi Nondiffuse Fatty Change of the Liver: Discerning Pseudotumor on MR Images Enhanced with Ferumoxides-Initial Observations Radiology, November 1, 2000; 217(2): 415 - 420. [Abstract] [Full Text] |
||||
![]() |
P. Reimer, N. Jähnke, M. Fiebich, W. Schima, F. Deckers, C. Marx, N. Holzknecht, and S. Saini Hepatic Lesion Detection and Characterization: Value of Nonenhanced MR Imaging, Superparamagnetic Iron Oxide-enhanced MR Imaging, and Spiral CT-ROC Analysis Radiology, October 1, 2000; 217(1): 152 - 158. [Abstract] [Full Text] |
||||
![]() |
H. Kondo, M. Kanematsu, H. Hoshi, T. Murakami, T. Kim, M. Hori, M. Matsuo, and H. Nakamura Preoperative Detection of Malignant Hepatic Tumors: Comparison of Combined Methods of MR Imaging with Combined Methods of CT Am. J. Roentgenol., April 1, 2000; 174(4): 947 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Inaba, Y. Arai, M. Kanematsu, Y. Takeuchi, K. Matsueda, K. Yasui, H. Hoshi, and Y. Itai Revealing Hepatic Metastases from Colorectal Cancer: Value of Combined Helical CT During Arterial Portography and CT Hepatic Arteriography with a Unified CT and Angiography System Am. J. Roentgenol., April 1, 2000; 174(4): 955 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. Sica, H. Ji, and P. R. Ros CT and MR Imaging of Hepatic Metastases Am. J. Roentgenol., March 1, 2000; 174(3): 691 - 698. [Full Text] [PDF] |
||||
![]() |
J. Ward, F. Chen, J. A. Guthrie, D. Wilson, J. P. A. Lodge, J. I. Wyatt, and P. J. Robinson Hepatic Lesion Detection after Superparamagnetic Iron Oxide Enhancement: Comparison of Five T2-weighted Sequences at 1.0 T by Using Alternative-Free Response Receiver Operating Characteristic Analysis1 Radiology, January 1, 2000; 214(1): 159 - 166. [Abstract] [Full Text] |
||||
![]() |
R. C. Semelka, W. G. Cance, H. B. Marcos, and M. A. Mauro Liver Metastases: Comparison of Current MR Techniques and Spiral CT during Arterial Portography for Detection in 20 Surgically Staged Cases Radiology, October 1, 1999; 213(1): 86 - 91. [Abstract] [Full Text] |
||||
![]() |
S. S. Yoon and K. K. Tanabe Surgical Treatment and Other Regional Treatments for Colorectal Cancer Liver Metastases Oncologist, June 1, 1999; 4(3): 197 - 208. [Abstract] [Full Text] |
||||
![]() |
M. Kanematsu, H. Hoshi, K. Itoh, T. Murakami, M. Hori, H. Kondo, R. Yokoyama, and H. Nakamura Focal Hepatic Lesion Detection: Comparison of Four Fat-suppressed T2-weighted MR Imaging Pulse Sequences Radiology, May 1, 1999; 211(2): 363 - 371. [Abstract] [Full Text] |
||||
![]() |
J. Ward, K. S. Naik, J. A. Guthrie, D. Wilson, and P. J. Robinson Hepatic Lesion Detection: Comparison of MR Imaging after the Administration of Superparamagnetic Iron Oxide with Dual-Phase CT by Using Alternative–Free Response Receiver Operating Characteristic Analysis Radiology, February 1, 1999; 210(2): 459 - 466. [Abstract] [Full Text] |
||||
![]() |
L. Grazioli, G. Morana, M. P. Federle, G. Brancatelli, M. Testoni, M. A. Kirchin, K. Menni, L. Olivetti, N. Nicoli, and C. Procacci Focal Nodular Hyperplasia: Morphologic and Functional Information from MR Imaging with Gadobenate Dimeglumine Radiology, December 1, 2001; 221(3): 731 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pauleit, J. Textor, R. Bachmann, R. Conrad, S. Flacke, G. Layer, B. Kreft, and H. Schild Hepatocellular Carcinoma: Detection with Gadolinium- and Ferumoxides-enhanced MR Imaging of the Liver Radiology, January 1, 2002; 222(1): 73 - 80. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |